Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691945 · ClinicalTrials.gov registry record · Phase 3
Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage
A Phase 3 study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- Phase 3
- Development phase
- 700
- Enrollment target
NCT06691945: Clinical Trial Phase 3 study, sponsored by The University of Texas Health Science Center, Houston.
NCT06691945 is a Phase 3 study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 700 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06691945, a Phase 3 study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 700 participants
- Enrollment target
Study Summary
The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion of any blood products or iii) hysterectomy
Interventions
- COMBINATION_PRODUCT Saline delivered using an intrauterine pressure catheter (IUPC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2027-05-01 |
| Phase | Phase 3 |
What is known before NCT06691945 opens enrollment
NCT06691945 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Saline delivered using an intrauterine pressure catheter (IUPC) is the first listed.
NCT06691945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06691945 about?
NCT06691945 is a clinical study titled "Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage". The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion of any blood products or iii) hysterectomy
What is the current status of trial NCT06691945?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 700 participants. The study started on 2024-11-11. Estimated completion is 2027-05-01.
What interventions are being tested in trial NCT06691945?
The interventions under investigation include: Saline delivered using an intrauterine pressure catheter (IUPC) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06691945?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06691945's enrollment target sits among peer trials
700 506th of 2000 higher than 1,485 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI